Chamber and committees

I refer the member to the answer to question S5W-07925 on 20 March 2017. All answers to written parliamentary questions are available on the Parliament's website, the search facility for which can be found at: http://www.parliament.scot/parliamentarybusiness/28877.aspx

The Scottish Government has engaged with ADPs and a range of partners to support and to review the effectiveness of service delivery, reflecting on this and balancing against the overall pressures on the Health budget, in setting the 2017-18 budget.

In 2016-17, NHS boards are expected to maintain spending on drug and alcohol treatment and recovery support services at 2015-16 levels, supplementing the Scottish Governments’ direct allocation from increased board baseline funding as required.

In 2017-18 specific funding of £53.8 million to support Alcohol and Drug Partnership work, will be added to board’s baseline funding and delegated to Integrated Authorities. As in previous years, the position remains that funds provided directly from the Scottish Government budget, sit alongside funds provided from other NHS sources (including NHS baseline funding), statutory partners and the third sector, which collectively makes up the resource package for this important work.

Decisions around the circumstances in which the use of mesh in any individual patient’s treatment is appropriate are a matter between the patient and the clinicians involved in her case. The Independent Review is expected to publish its final report during the spring. Health Boards will take appropriate action depending on the report's recommendations.

Non-mesh treatments include both surgical and non-surgical interventions. Surgical interventions include the use of simple suture repairs or the use of host native tissue.

I understand that all relevant evidence available has been considered by the Review. The passage of time between the publication of the Interim Report and the forthcoming Final Report is due to the Review awaiting the publication of several key studies.

I refer the member to the answer to question S5W-07740 on 17 March 2017. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at http://www.parliament.scot/parliamentarybusiness/28877.aspx

Informed consent and shared decision making are expected prior to any procedure being carried out. The Chief Medical Officer goes into this in more detail in her Realistic Medicine report.

http://www.gov.scot/Resource/0051/00514513.pdf.

Adverse incidents involving any medical device must be reported as per General Medical Practice guidance.

The Independent Review has met three times since the publication of the interim report: March 2016, January 2017 and March 2017.

I understand that attempts have been made to make the Review’s final report as accessible as possible. However, as with any report of this kind, it will contain necessarily detailed, in-depth analysis of medical evidence that is, by its very nature, complex. An Expert Group is tasked with taking forward the recommendations of the Review. In response to previous recommendations it produced a patient-centred information and consent leaflet, and it will be expected to continue to take a patient-friendly approach in relation to the Review’s final recommendations.